LYVGEN BIOPHARMA CO., LTD

Follow

Organization

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-CD40 antibody having engineered Fc domains and therapeutic use...
- Patent number 11,186,648
- Issue date Nov 30, 2021
- LYVGEN BIOPHARMA CO., LTD.
- Jieyi Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD40 BINDING MOLECULES HAVING ENGINEERED FC DOMAINS AND THERAP...
- Publication number 20220081487
- Publication date Mar 17, 2022
- LYVGEN BIOPHARMA (SUZHOU) CO., LTD.
- Jieyi WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40 BINDING MOLECULES HAVING ENGINEERED FC DOMAINS AND THERAP...
- Publication number 20210301029
- Publication date Sep 30, 2021
- LYVGEN BIOPHARMA CO., LTD.
- Jieyi WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-CD137 ANTIBODIES AND USES THEREOF
- Publication number 20210246218
- Publication date Aug 12, 2021
- LYVGEN BIOPHARMA (SUZHOU) CO., LTD.
- Jieyi WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD40 ANTIBODIES AND USES THEREOF
- Publication number 20210179727
- Publication date Jun 17, 2021
- LYVGEN BIOPHARMA CO., LTD.
- Jieyi Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD137 ANTIBODIES AND USES THEREOF
- Publication number 20200385479
- Publication date Dec 10, 2020
- LYVGEN BIOPHARMA CO., LTD.
- Jieyi WANG
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks